PriMed Technologies to Increase Revenues With Extension of Agreement With Madeline, LLC & Is Proceeding With Nationwide Expansion

Apr 24, 2001, 01:00 ET from AmeriNet Group.com, Inc.

    BOCA RATON, Fla., April 24 /PRNewswire Interactive News Release/ --
 AmeriNet Group.com, Inc. (OTC Bulletin Board:   ABUY) ("AmeriNet") noted that
 PriMed Technologies, Inc., a Delaware corporation ("PriMed") which is a party
 to a consulting agreement pursuant to which AmeriNet stockholders will receive
 10% of PriMed's common stock, has announced that it has entered into a
 material contract.  The PriMed release is provided below in compliance with
 AmeriNet's obligations to prevent selective disclosure pursuant to recently
 promulgated Commission regulation FD.
 
     PriMed Technologies, Inc. has announced an extension of its agreement with
 Madeline, LLC, a fund under management by Cerberus Capital Management, a
 multi-billion dollar New York hedge fund.  The contract references over
 $16,000,000 of accounts that are to be managed.
     PriMed has been providing Madeline, LLC with administrative and accounts
 receivable recovery services for the past several years in connection with
 their fund's financing of a physicians practice management company that
 previously owned seven medical practices in Miami-Dade and Broward County,
 Florida.
     "We expect this agreement to result in a 25% increase in revenue from the
 second to the third quarter," said Evan Brovenick, chief executive officer of
 PriMed Technologies.
     Seth P. Plattus, managing director, Cerberus Capital Management, added,
 "We look forward to continuing this mutually beneficial agreement with
 PriMed."
     PriMed Technologies, Inc. provides proven management and financial
 expertise along with the latest on-line technologies to its growing client
 base of physicians, hospitals and ancillary service organizations in South
 Florida.  Nationwide expansion has already begun with a project now underway
 in Washington, D.C.
     AmeriNet is a publicly traded holding company, which files periodic
 reports with the Securities and Exchange Commission.
     For additional information about Primed Technologies, Inc., contact Andrew
 M. Rose at Marketing Ink, Inc.: (954) 428-2678, andy@marketingink.net; or for
 AmeriNet Group, contact Charles J. Scimeca, Tel: 561-998-3435, Fax
 561-998-4635, E-mail info@amerinetgroup.com,  Website www.amerinetgroup.com .
     This press release contains certain "forward-looking statements" and the
 information (as defined in the Private Securities Litigation Reform Act of
 1995) concerning AmeriNet and PriMed that are based on the beliefs of
 AmeriNet's and PriMed's management, as well as assumptions made by and
 information currently available to Primed and AmeriNet.  Such statements
 reflect the current views of PriMed and AmeriNet with respect to future events
 and are subject to certain assumptions, including those described in this
 release.  Should one or more of the underlying assumptions prove incorrect,
 actual results may vary materially from those described herein as anticipated,
 believed or expected.  PriMed and AmeriNet does not intend to update these
 forward-looking statements prior to announcement of quarterly or annual
 results.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X02475728
 
 

SOURCE AmeriNet Group.com, Inc.
    BOCA RATON, Fla., April 24 /PRNewswire Interactive News Release/ --
 AmeriNet Group.com, Inc. (OTC Bulletin Board:   ABUY) ("AmeriNet") noted that
 PriMed Technologies, Inc., a Delaware corporation ("PriMed") which is a party
 to a consulting agreement pursuant to which AmeriNet stockholders will receive
 10% of PriMed's common stock, has announced that it has entered into a
 material contract.  The PriMed release is provided below in compliance with
 AmeriNet's obligations to prevent selective disclosure pursuant to recently
 promulgated Commission regulation FD.
 
     PriMed Technologies, Inc. has announced an extension of its agreement with
 Madeline, LLC, a fund under management by Cerberus Capital Management, a
 multi-billion dollar New York hedge fund.  The contract references over
 $16,000,000 of accounts that are to be managed.
     PriMed has been providing Madeline, LLC with administrative and accounts
 receivable recovery services for the past several years in connection with
 their fund's financing of a physicians practice management company that
 previously owned seven medical practices in Miami-Dade and Broward County,
 Florida.
     "We expect this agreement to result in a 25% increase in revenue from the
 second to the third quarter," said Evan Brovenick, chief executive officer of
 PriMed Technologies.
     Seth P. Plattus, managing director, Cerberus Capital Management, added,
 "We look forward to continuing this mutually beneficial agreement with
 PriMed."
     PriMed Technologies, Inc. provides proven management and financial
 expertise along with the latest on-line technologies to its growing client
 base of physicians, hospitals and ancillary service organizations in South
 Florida.  Nationwide expansion has already begun with a project now underway
 in Washington, D.C.
     AmeriNet is a publicly traded holding company, which files periodic
 reports with the Securities and Exchange Commission.
     For additional information about Primed Technologies, Inc., contact Andrew
 M. Rose at Marketing Ink, Inc.: (954) 428-2678, andy@marketingink.net; or for
 AmeriNet Group, contact Charles J. Scimeca, Tel: 561-998-3435, Fax
 561-998-4635, E-mail info@amerinetgroup.com,  Website www.amerinetgroup.com .
     This press release contains certain "forward-looking statements" and the
 information (as defined in the Private Securities Litigation Reform Act of
 1995) concerning AmeriNet and PriMed that are based on the beliefs of
 AmeriNet's and PriMed's management, as well as assumptions made by and
 information currently available to Primed and AmeriNet.  Such statements
 reflect the current views of PriMed and AmeriNet with respect to future events
 and are subject to certain assumptions, including those described in this
 release.  Should one or more of the underlying assumptions prove incorrect,
 actual results may vary materially from those described herein as anticipated,
 believed or expected.  PriMed and AmeriNet does not intend to update these
 forward-looking statements prior to announcement of quarterly or annual
 results.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X02475728
 
 SOURCE  AmeriNet Group.com, Inc.